|Day Low/High||2.90 / 3.08|
|52 Wk Low/High||2.67 / 4.23|
However, supply constraints continue to hinder growth and drive up home prices; impact of tax reform expected to be a net positive
With the bulls apparently back in charge, for now, here are three overlooked names with big potential.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CG, FLO, GNW, IART, LITE, MX, PDVW, PFPT, STO, TTWO Downgrades: AINV, BCO, BZH, CRCM, GSIT, GSK, IESC, ISRL, MLAB, MTCH, NEU, NNN, PZN, SGA Initiations: TRVG Read on to get TheStreet Quant Ratings' detailed report:
Jim discusses GE, Citigroup's earnings, Facebook's update to its news feed update, and our price target for Activision.
Hitchings, with 32 years of experience, will support Genworth's market-leading HFA segment
Investors in Genworth Financial, Inc. saw new options begin trading today, for the March 2nd expiration.
Investors in Genworth Financial, Inc. saw new options begin trading this week, for the February 2018 expiration.
Partially offsets slowdown in overall housing market as rising home prices suppress demand from repeat homebuyers
Investors in Genworth Financial, Inc. saw new options become available today, for the January 2020 expiration.
The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 1,633,609 share increase in total short interest for Genworth Financial, Inc. , to 12,061,113, an increase of 15.67% since 10/13/2017.
Investors in Genworth Financial, Inc. saw new options become available today, for the December 29th expiration.
Jim Cramer is bullish on Exact Sciences, Cognizant Technology, MetLife, JPMorgan Chase and more.
Sentiment is critical to the next market move, says Jim Cramer. A little negativity is great news for the bulls.
Findings point to overwhelming confusion about who pays for care
Re-enforces firm's continued focus on technological infrastructure innovation
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.